References
- Rosenberg M. J., Long S. C. Oral contraceptives and cycle control: a critical review of the literature. Contraception 1992; 8(Suppl. 1)
- Rosenberg M., Waugh M. Orgal contraceptives and cycle control: are the new progestogens better?. Med. Dial. 1994; 415
- Latin American Oral Contraceptive Study Group. Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl-estradiol and desogestrel/ethinylestradiol. Contraception 1994; 50: 201–14
- Düsterberg B., Beier S., Schneider W. H. F., Spona J. Pharmacological features of gestodene in laboratory animals and man. Gestodene, a New Direction in Oral Contraception, M. Breckwoldt, B. Düsterberg. Parthenon Publishing, Carnforth, UK 1988; 13–29
- Brill K., Norpoth T., Schnitker J., Albring M. Clinical experience with a modern low dose oral contraceptive in almost 100,000 users. Contraception 1991; 43: 101–10
- Yuzpe A. A. Triphasic levonorgestrel: its role in oral contraception. Gynecol. Endocinol. 1995; 9(Suppl. 2)29–37
- Brill K., Müller C., Schnitker J., Albring M. The influence of different low-dose oral contraceptives on intermenstrul bleeding. Adv. Contracept. 1991; 7(Suppl. 2)51–61
- Moos R. H. The development of a menstrual distress questionnaire. Psychosom. Med. 1968; 30: 853–67
- Markum R. Assessment of the reliability of and the effect of neutral instructions on the symptom ratings on the Moos Menstrual Distress Questionnaire. Psychosom. Med. 1976; 38: 163–72
- Gruba G. H., Rohrbaugh M. MMPI correlates of menstrual distress. Psychosom. Med. 1975; 37: 265–72
- Brooks J., Ruble D., Clark A. College women's attitudes and expectations concerning menstrual-related changes. Psychosom. Med. 1977; 39: 288–98
- Paige K. E. Effects of oral contraceptives on affective fluctuation in the menstrual cycle. Psychosom. Med. 1900; 171: 515–37
- Rube T., Maletz-Kehry W., Leppien G., Forrsman W. G., Gmeiner C., Runnebaum B. Clinical update on triphasic gestodene. Gynecol. Endocrinol. 1993; 7(Suppl.)25–32
- Andrade R. P. Clinical comparison of a triphasic gestodene preparation and a monophasic desogestrel preparation. Gynecol. Endocrinol. 1993; 7(Suppl.)33–41